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Abstract 
As a poorly water-soluble chemical, penfluridol is used as a maintenance drug for individuals with 
chronic schizophrenia. A novel self-microemulsifying drug delivery system has been successfully 
developed to benefit the solubility of penfluridol. Pseudo-ternary phase diagrams were constructed to 
investigate the phase behaviour and to assess the effects of different co-surfactants and the mass ratios of 
surfactant to co-surfactant (Km) on the phase regions. Optimal compositions of the formed systems were 
screened via viscosity studies and microemulsion droplet size tests. The optimal formulation of 
penfluridol-loaded self-microemulsion consists of penfluridol 5.0%, oil (MCT) 15.8%, surfactant 
(cremophor EL) 52.8%, co-surfactant (PEG-400) 26.4%, with the average particle size at approximately 
(53.5±4.3) nm. Transmission electron microscopy (TEM) revealed the spherical nature and size 
homogeneity of the microemulsion droplets. No significant variations (droplet sizes and penfluridol 
contents) in microemulsion were observed over a period of 30 days at 4 °C and 25 °C, respectively. The 
developed self-microemulsion proved to be a potential candidate to enhance the solubility of penfluridol.a 
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Selection and/or peer-review under responsibility of Society for Resources, Environment and Engineering 
Keywords: penfluridol; self-microemulsifying drug delivery system; phase behaviour
1 Introduction 
* Corresponding author. Tel.: +86-137-7589-5636; fax: +86-516-8326-2136. 
E-mail address: cbpe200901@163.com.
Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license.
60  Xuemei Zhuang et al. / Procedia Engineering 18 (2011) 59 – 652 Author name / Procedia Engineering 00 (2011) 000–000 
As a highly lipophilic oral neuroleptic, penfluridol can be released at a slow pace from the tissues 
following ingestion. A single oral dose of penfluridol results in a long duration of activity[1]. Despite this 
remarkable long-term effect, its peak blood levels are achieved at 4 to 6 h, more typically at 6 h[2] after 
administration. The retarded dissolution of penfluridol brings about its slow response to schizophrenia. 
As a novel drug delivery system, self-emulsifying drug delivery systems (SMEDDS) are isotropic 
mixtures of oil, surfactant, co-surfactant and drug[3, 4]. SMEDDS offer numerous advantages such as 
spontaneous formation, thermodynamic stability, improved bioavailability and feasibility for preparation. 
Enhanced solubility and improved bioavailability are amongst the main advantages of SMEDDS[5, 6]. 
The objectives of our present study were to formulate penfluridol-loaded self-microemulsion and 
assess its physicochemical characterisation. The solubility of penfluridol was determined in various 
vehicles. To sieve out the optimal formulation, the viscosity studies and microemulsion droplet size tests 
were conducted. The spherical nature and size homogeneity of the microemulsion droplets were revealed 
by transmission electron microscopy. 
 
2 Materials and methods 
2.1 Materials 
The chemicals are described as follows: penfluridol (Jiangsu Nhwa Pharmaceutical Co., Ltd., 
Jiangsu, China), soybean oil and medium chain triglyceride (MCT) (Tieling Beiya Pharmaceutical Oil 
Co., Ltd., Tieling, China), polyethylene glycol 400 (PEG-400) and polysorbate 80 (Qingdao Tianliyuan 
Biotechnology Co., Ltd., Qingdao, China), propylene glycol and glycerol (Jiangxi Ipsen Pharmaceutical 
Co., Ltd., Jiangxi, China), cremophor EL (BASF, Ludwigshafen, Germany), and methanol of HPLC 
grade (Merck KGaA, Darmstadt, Germany). All the other chemicals were of reagent grade. 
 
2.2 HPLC analysis of penfluridol
 
The concentration of penfluridol was determined by HPLC method. The system consists of Agilent 
1100 series with a UV detector. All samples were analysed using a platinum C18-EPS column (5 μm, 
4.6×250 mm) with the thermostat set at 25 °C. The mobile phase was methanol/0.2% triethylamine (70: 
30, v/v) with pH adjusted to 2.5 by phosphoric acid and delivered at a flow rate of 1.0 ml/min. A volume 
of 20 µl was injected into the system to determine the concentration of penfluridol at 219 nm. 
 
2.3 Solubility studies 
To sieve out the appropriate oil (soybean oil, MCT), surfactants (polysorbate 80, cremophor EL) and 
co-surfactants (propylene glycol, glycerol and PEG-400) of self-microemulsion, the solubility of 
penfluridol in various vehicles was investigated by HPLC method. Each vehicle (10 ml) was permitted 
addition of an excess amount of penfluridol in a sealed flat-bottomed flask and ultrasonic wave (300 w, 5 
min) was employed to facilitate the solubility. The resultant mixture was reciprocally agitated at 25 °C for 
72 h in a water bath, followed by centrifugation at 14000 rpm for 10 min. The supernatant was filtered 
through a membrane filter (0.45 μm) to remove the residual insoluble penfluridol. Subsequently, 0.1 ml 
supernatant was obtained for penfluridol quantification by spectrophotometry at 219 nm following 
dilution to 10 ml with methanol. The concentration of penfluridol in the filtrate was quantified by high 
performance liquid chromatography (HPLC). 
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2.4 Construction of pseudo-ternary phase diagrams 
On the basis of the solubility studies, pseudo-ternary phase diagrams were constructed with water 
titration method to obtain the o/w microemulsion region, within which the concentration range of the 
components was identified. The weight ratio of surfactant to co-surfactant (Km) was varied as 1:2, 1:1, 2:1. 
For each pseudo-ternary phase diagram at a specific Km, the ratio of oil to the surfactant/co-surfacant 
mixture was varied form 9:1 to 1:9 at 10% increments. The mixture of oil, surfactant and co-surfactant at 
certain weight ratio was titrated with double-distilled water dropwise under proper magnetic stirring at 
25 °C. When the mixture became transparent at a certain time point, the concentrations of the components 
were recorded to complete the pseudo-ternary phase diagrams. Subsequently, co-surfactants were 
screened on the basis of the range of o/w microemulsion obtained from their pseudo-ternary phase 
diagrams. 
 
2.5 Preparation and selection of penfluridol-loaded self-microemulsion 
The contents of oil, surfactant, co-surfactant and water at defined weight ratios were screened to 
optimise the microemulsion. Briefly, MCT (1.0 g) and Smix were mixed at the weight ratios of 1:4, 1:5, 
1:6, 1:7 and 1:8. Then, the formulations (M1 to M5) were prepared as aforementioned and were checked 
for the viscosity as well as the mean droplet size to screen the optimal formulation. Based on the results 
of formulation screening, microemulsion formulations at the desired component ratio were prepared (with 
penfluridol loaded or unloaded). Subsequently, the resulting self-microemulsions were sealed in ampoules 
for physicochemical characterisation. 
 
2.6 Viscosity measurements 
The microemulsions (M1 to M5) were determined with a digital viscometer (Shanghai Precision and 
Scientific Instrument Co., Ltd., China) at 25±1 °C. The viscosity behaviour of each disperse system was 
evaluated at 30 rpm, with the results recorded for formulation selection. 
 
2.7 Dynamic light scattering measurements 
Dynamic light scattering was employed to determine the droplet sizes of selected microemulsions. 
The measurements were performed with a Zetasizer 3000 HS (Malvem Instruments, Worcestershire, UK). 
Light scattering was measured at a scattering angle of 90° at 25 °C, with polystyrene beads as the 
criterion. A cumulant-based algorithm that fitted a single exponential to the correlation function was 
designated for the mean droplet diameter and an estimate of the droplets size distribution. 
 
2.8 Transmission electron microscopy (TEM) 
As a visualising aid, the morphology of the optimal blank and penfluridol-loaded self-microemulsion 
was observed under a transmission electron microscope (TEM) (H600, Hitachi, Japan). Formvar/ Carbon-
coated 200 mesh copper grids were glow discharged and samples were diluted with distilled water (1:50). 
One drop of diluted samples was dripped on a film-coated copper grid and dried down. 30 µl saturated 
staining solution of uranyl acetate was added and the mixture was immediately dried down with filter 
paper to rid excess colorant, followed by imaging of the dried specimens by TEM. 
 
2.9 Stability studies 
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The stability of the optimised penfluridol-loaded microemulsion sealed in ampoules was assessed in 
temperature and centrifugation tests[7], wherein samples were subjected to different temperatures (4, 25 
and 60 °C), withdrawn in triplicate on 0, 15th and 30th day, and evaluated for their physical stability, 
including the macroscopic appearance of the samples, droplet size of the internal phase of the 
microemulsion within 100 nm and viscosity of the disperse system. In the centrifugation test, the samples 
were submitted to a centrifuge at 14,000 rpm for 20 min and assessed for their macroscopic appearance. 
 
3 Results and discussion 
3.1 HPLC analysis of penfluridol 
 
The method was demonstrated for accuracy, precision, specificity and solution stability for 
penfluridol detection. The linear range was between 4.0 and 32.0 µg/ml, and the mean calibration curve 
was obtained by the equation: 
y =0.04498 x+0.0338                                                                                                                          (1) 
With a correlation coefficient, r2=0.9998, where y represents area under the curve and x represents 
the concentration of penfluridol in microgram per millilitre. 
 
3.2 Solubility studies 
Solubility of penfluridol in nine vehicles was presented in Tab. 1. The solubility of penfluridol in 
MCT, cremophor EL and PEG-400 was up to 192.97 mg/ml, 166.30 mg/ml and 132.79 mg/ml. Due to the 
improvability of oil phase on drug entrapment in the self-microemulsion, of 2 tested oils (MCT and 
soybean oil), MCT exhibited better solubility of penfluridol. Hence, MCT was designated as the oil phase. 
Meanwhile, cremophor EL served as the surfactant on the basis of the higher solubility of penfluridol. 
 
3.3 Phase behaviour studies 
To investigate the phase behaviour of the identified surfactant/co-surfactant, oil and water mixture 
and identify the optimum microemulsion area, pseudo-ternary phase diagrams were constructed, 
consisting of MCT, cremophor EL, distilled water and different co-surfactants as described in Fig. 1, 
which showed the effects of different co-surfactants and weight ratios of surfactant to co-surfactant (Km) 
on the phase regions. A co-surfactant is an amphiphilic molecule that substantially accumulates with the 
surfactant at the interfacial layer. The presence of co-surfactant allows the interfacial film sufficient 
flexibility to take up different curvatures required to form microemulsion over a wide range of 
compositions[8]. In our study, the largest o/w microemulsion region was obtained with a Km value of 2:1 
in the MCT/cremophor EL/PEG-400. Therefore, it was reasonable to designate PEG-400 as the co-
surfactant. Furthermore, clear isotropic microemulsions of the selected system were formulated for 
further characterisation with the weight ratios of Smix to oil (MCT) set at 3:1, 4:1, 5:1, 6:1, 7:1 (M1 to M5) 
and a total microemulsion weight of 20.0 g (Table 2). 
 
3.4 The optimal formulation selection by measurements of droplet size and viscosity 
 
The droplet sizes and viscosities of the microemulsions (M1 to M5) are presented in Tab. 2. The 
droplet sizes of microemulsions (M1 to M3) significantly diminished with the increasing concentrations of 
the surfactant, but increased in M4 and M5. Structurally, the dispersed phase of microemulsion consists of 
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microstructures of oil-entrapped pockets stabilised by surfactant/ co-surfactant accumulation on the 
oil/water boundary. Furthermore, the addition of surfactants caused the interfacial film to stabilise and 
condense. Thereby, the droplet sizes of microemulsions (M1 to M3) decreased with the increasing 
surfactant concentrations. However, the structures of microemulsion coexist in equilibrium, with their 
relative abundance determined by the proportions of different components. Owing to the relatively small 
percentages of oil in prescription, M4 and M5 were adjacent to the liquid crystalline phases, i.e., 
viscoelastic gels, which were not sufficiently emulsified and had increased particle sizes. 
 
Tab. 1. Solubility results of penfluridol at 25 °C in various vehicles (mean ± S.D.; n = 3) 
 










117.38±0.09 192.97±0.03 126.27±0.21 166.30±0.29 126.95±0.11 119.60±0.18 132.79±0.07 
 
Tab. 2. Calculation of percentage of oil, Smix and water used in the optimal formulation selection based on the viscosity and droplet 












M1 23.75 71.25 5.0 10.4 89.4±6.9 
M2 19.0 76.0 5.0 19.0 75.1±5.5 
M3 15.8 79.2 5.0 26.8 53.5±4.3
M4 13.6 81.4 5.0 49.8 60.7±7.3 
M5 11.9 83.1 5.0 60.7 71.7±9.8 
 
            
 
Fig. 1. Pseudo-ternary phase diagrams of microemulsion. (A) MCT/Cremophor EL/ Glycerol (Km = 2:1). B, 
MCT/Cremophor EL/ Propylene glycol (Km = 2:1). C, MCT/ Cremophor EL/ PEG-400 (Km = 2:1). D, MCT/ 
Cremophor EL/PEG-400 (Km = 1:2). E, MCT/Cremophor EL/PEG-400 (Km = 1:1). 
 
Fig. 2. TEM photographs of penfluridol-loaded self-microemulsion 
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As presented in Tab. 2, the results also showed an increase in the values of viscosity coupled with 
the rise of Smix content. These results could be attributed to the increased proportion of surfactant relative 
to co-surfactant. Furthermore, there are reports that surfactants and co-surfactants can be toxic at high 
doses, so they may be limited in their daily and per-dose intake level[9]. As mentioned above, a high 
concentration (over 80%) of Smix is thus inappropriate for the formulations. Besides, the relative ratio of 
surfactant to co-surfactant has modified effects on the droplet size when Smix to oil reaches the suitable 
weight ratio. Consequently, M3 (MCT 15.8%, cremophor EL 52.8%, PEG-400 26.4%) with penfluridol 
(5%) was selected as the optimal self-microemulsion. 
3.5 Transmission electron microscopy (TEM) and droplet size distribution measurement of the optimal 
microemulsion
Morphological characterisation of the optimal self-microemulsion was presented by TEM (Fig. 2). 
The droplet on the microemulsion appears black with the white surrounding. TEM photographs 
confirmed that the droplets were well-dispersed with no aggregation or cluster formation, spherical in 
shape, uniform and appreciably homogeneous with particulate sizes. The size distribution of the blank 
and the penfluridol-loaded self-microemulsion by dynamic light scattering technique was depicted. The 
blank formulation had an average droplet size of 29.7 nm, whereas the penfluridol-loaded microemulsion 
had an average droplet size of 53.5 nm. On the one hand, the addition of penfluridol caused an increase in 
size of larger droplets at the expense of smaller droplets[10]. On the other hand, as the preconcentrated 
microemulsion is diluted, the structure might transform from small to large droplets[11]. 
 
3.6 Stability tests 
Evaluations of temperature stability of self-microemulsions suggested that the optimal self-
microemulsions were still stable under all conditions except a temperature of 60 °C on account of opacity 
on their macroscopic appearance at the end of the experiment. It was probably due to both the 
temperature-induced oxidation of the MCT and the gradual increase of particle sizes of the 
microemulsions. Self-microemulsions submitted to the centrifugation test appeared stable, for no 
stratification phenomenon was observed at the end of the study. 
 
4 Conclusions 
A novel self-micromeulsifying drug delivery system of penfluridol was formulated and 
physicochemically characterised by in vitro parameters such as viscosity, particle size, stability tests and 
morphology characterisation. An optimal self-micromeulsifying drug delivery system consists of MCT as 
oil phase, cremophor EL as surfactant, and PEG-400 as co-surfactant. The combination of all the three 
components, i.e., oil/surfactant/co-surfactant in the ratio of 1.5: 4: 2, formulates SMEDDS with a lower 
particle size of 53.5 nm. The optimised SMEDDS showed good solubilisation of penfluridol. Our study 
illustrated the application potential of self-microemulsifying drug delivery system to enhance the 
solubilisation of penfluridol. 
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